|
2024
|
Invention
|
Bax activators and use thereof. Disclosed herein are small molecule activators of the B-cell lymp... |
|
|
G/S
|
Pharmaceutical preparations. |
|
2023
|
Invention
|
Melanocortin receptor ligands modified with hydantoin.
The present invention relates to peptide ... |
|
2022
|
G/S
|
Pharmaceutical preparations
Medical apparatus and instruments; Surgical apparatus and instruments... |
|
|
G/S
|
Pharmaceutical preparations for use in the prevention and the treatment of cancer, orphan disease... |
|
|
Invention
|
Use of melanocortins to treat insulin sensitivity.
The present invention relates to peptide liga... |
|
|
G/S
|
Pharmaceutical preparations for treatment of oncologic and endocrine conditions Medical apparatus... |
|
|
G/S
|
Pharmaceutical preparations. Surgical apparatus and instruments; Medical apparatus and instrument... |
|
|
G/S
|
Pharmaceutical preparations. Autoinjectors for the administration of pharmaceutical preparations;... |
|
|
G/S
|
Pharmaceutical preparations. Medical apparatus and instruments; Surgical apparatus and instrument... |
|
|
G/S
|
Pharmaceutical preparations.
Medical apparatus and instruments; Surgical apparatus and instrument... |
|
|
G/S
|
Pharmaceutical preparations in the field of oncology, namely, for the treatment of oncological di... |
|
|
G/S
|
Pharmaceuticals; Pharmaceutical preparations. Medical apparatus and instruments; Surgical apparat... |
|
|
G/S
|
Pharmaceutical preparations. Injectors for medical purposes; Autoinjectors for the administration... |
|
|
Invention
|
Melanocortin receptor ligands.
The present invention is directed to compounds according to formu... |
|
2021
|
Invention
|
Tasquinimod or a pharmaceutically acceptable salt thereof for use in combination therapy.
A comb... |
|
2020
|
Invention
|
Method of treating osteoporosis comprising administration of pthrp analog. The present invention ... |
|
|
G/S
|
Clinical trials; Conducting clinical trials for pharmaceutical products; Providing medical and sc... |
|
|
Invention
|
Method for inhibiting inflammation and pro-inflammatory cytokine/chemokine expression using a ghr... |
|
2019
|
Invention
|
Composition and methods for stimulating gastrointestinal motility.
The present invention relates... |
|
|
Invention
|
Growth hormone releasing peptides.
Disclosed are peptide and peptidomimetic compounds generally ... |
|
|
Invention
|
Composition containing a somatostatin analogue for radiopharmaceutical use. The present invention... |
|
2018
|
Invention
|
Process for the preparation of pharmaceutical compositions for the sustained release of somatosta... |
|
2017
|
Invention
|
Melanocortin receptor ligands.
and pharmaceutically-acceptable salts thereof that act as ligands... |
|
2016
|
Invention
|
Formulation for hgh and rhigf-1 combination.
Pharmaceutical compositions, in particular, composi... |
|
|
Invention
|
Compositions and methods for treatment of pain. Embodied herein are engineered fusion proteins th... |
|
|
Invention
|
Use of melanocortins to treat insulin sensitivity. The present invention relates to peptide ligan... |
|
|
Invention
|
Melanocortin receptor ligands modified with hydantoin. The present invention relates to peptide l... |
|
|
Invention
|
Combination of tasquinimod or a pharmaceutically acceptable salt thereof and a pd-1 and/or pd-l1 ... |
|
|
Invention
|
Pharmaceutical compositions of growth hormone secretagogue receptor ligands.
The present inventi... |
|
2015
|
Invention
|
Macrocyclic lrrk2 kinase inhibitors. The present invention relates to novel macrocyclic compounds... |
|
|
Invention
|
Analogues of glucose-dependent insulinotropic polypeptide.
There is provided a series of glucose... |
|
|
Invention
|
Glucose-dependent insulinotropic polypeptide analogues.
There is provided a novel series of anal... |
|
|
Invention
|
N-end rule protease activity indication methods and uses thereof. A cell based assay for detectio... |
|
2014
|
Invention
|
Aqueous sustained release compositions of lhrh analogues.
An aqueous pharmaceutical composition ... |
|
|
Invention
|
Pharmaceutical composition for a sustained release of lanreotide. A pharmaceutical composition fo... |
|
|
Invention
|
Novel method for purifying polyesters.
The invention relates to a method for purifying a polyest... |
|
2013
|
Invention
|
Imidazolidine-2,4-dione dervatives. Imidazolidine-2,4-dione derivatives of formula (I):
These c... |
|
|
Invention
|
Imidazolidine-2,4-dione derivatives. Imidazolidine-2,4-dione derivatives of formula (I):
The... |
|
|
Invention
|
Somatostatin-dopamine chimeric analogs. The present invention relates to novel somatostatin-dopam... |
|
|
Invention
|
Somatostatin analogs and dimers thereof. The present invention relates to novel somatostatin anal... |
